KDAc Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

KDAc Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $604,712 in total, most recently in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

KDAc Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Employees (self-reported, 2016)2

What does KDAc Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $604,712 in total (2016). NIH funding came from the National Institute on Drug Abuse, National Institute of Mental Health.

Frequently asked questions about KDAc Therapeutics

Where is KDAc Therapeutics headquartered?

KDAc Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does KDAc Therapeutics do?

KDAc Therapeutics, Inc. is a biotechnology company.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences